Company Overview

Greiner Bio-One, a global leader in biotechnology, diagnostics, and medical devices, offers solutions through its 28 subsidiaries worldwide having presence in every region. With over 2,300 employees, they provide tailored solutions to meet specific needs, ensuring quality, innovation, and customer satisfaction in their products and services.

Greiner Bio-One is supporting a groundbreaking collaboration between Scripps Florida, Cold Spring Harbor Laboratory, and Nano3D Biosciences Inc. This NIH-funded project aims to accelerate cancer drug discovery by developing automated, high-throughput 3D spheroid screening technologies.